RT期刊文章SR电子T1准确预测结果对脑出血患者更有可能比不准确预测影响并发症不包括在临床量表(S39.006)摩根富林明神经病学神经学乔FD Lippincott Williams &威尔金斯SP S39.006 VO 84 14补充A1大卫卡梅隆黄A1戴尔A1玛丽火花A1蒂芙尼沃森A1卡尔Langefeld A1玛丽Comeau A1乔纳森Rosand A1托马斯电池A1塞巴斯蒂安·科赫A1马里奥·佩雷斯A1 Michael James A1杰西首页卡McFarlin A1珍妮弗·奥斯本A1丹尼尔吸引A1史蒂文Kittner A1凯文Sheth年2015 UL //www.ez-admanager.com/content/84/14_Supplement/S39.006.abstract AB目的:我们假设医生准确预测的功能结果脑出血(我)患者更有可能比不准确的预测将决策因素以外的变量包括我和FUNC分数。背景:临床量表我,如我和得分函数,利用有限数量的变量对结果的预测。医生的变量纳入我的主观预测结果以及它们与预测精度是未知的。设计/方法:连续每个成人病人承认主中心,5点我一个医生的治疗团队调查预测改良Rankin规模(夫人)3个月。所有的预测都是前瞻性收集在24小时内入院。医生也要求显示多达10个影响因素的预测。精度定义为的精确预测三个月由内科医生太太重复的频率因素列出计算精确和准确预测使用确切概率法和比较。结果:我们收集了86 38精确和准确预测124年我的病人。之间没有区别组织关于受访者的比例清单的年龄,我体积,或一般临床考试录取的因素。然而,16 (42.1 [percnt])列出的准确调查病人的一般并发症因素预测,相比20 (23.3 [percnt])的不准确的调查(p = 0.05)。 Listing of pre-morbid functional status as a factor also trended towards a higher percentage in the accurate survey group (n = 7, 18.4[percnt], versus n = 6, 7.0[percnt]; p = 0.11). CONCLUSIONS: Accurate predictions of ICH outcome are more likely than inaccurate predictions to factor in general patient co-morbidities, which are not included in ICH or FUNC Score calculation. Study Supported by: AHA Clinical Research Training Award and NINDS U-01-NS069763Disclosure: Dr. Hwang has received personal compensation for activities with Bayer HealthCare as a consultant. Dr. Dell has nothing to disclose. Dr. Sparks has nothing to disclose. Dr. Watson has nothing to disclose. Dr. Langefeld has nothing to disclose. Dr. Comeau has nothing to disclose. Dr. Rosand has nothing to disclose. Dr. Battey has nothing to disclose. Dr. Koch has nothing to disclose. Dr. Perez has nothing to disclose. Dr. James has received personal compensation for activities with Hospira and Cephalogics as a consultant and/or speaker. Dr. McFarlin has nothing to disclose. Dr. Osborne has received research support from the National Institutes of Health. Dr. Woo has received research support from the National Institutes of Health. Dr. Kittner has nothing to disclose. Dr. Sheth has received research support from the American Academy of Neurology Foundation, the American Heart Association, the Passano Foundation, and Remedy Pharmaceuticals.Thursday, April 23 2015, 1:00 pm-2:45 pm